Cancer Research AACR Legacy  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 55, 4627-4632, October 15, 1995]
© 1995 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nannmark, U.
Right arrow Articles by Basse, P. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nannmark, U.
Right arrow Articles by Basse, P. H.

Microvessel Origin and Distribution in Pulmonary Metastases of B16 Melanoma: Implication for Adoptive Immunotherapy1

Ulf Nannmark, Bengt R. Johansson, John L. Bryant, Martin L. Unger, Marianne E. Hokland, Ronald H. Goldfarb and Per H. Basse2

Department of Anatomy and Cell Biology, University of Göteborg, Göteborg, Sweden [U. N., B. R. J., M. L. U.]; University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania [U. N., J. L. B., R. H. G., P. H. B.]; Department of Mathematics and Statistics, University of Pittsburgh, Pittsburgh, Pennsylvania [J. L. B.]; and Institute of Medical Microbiology, University of Århus, Århus, Denmark [M. E. H., P. H. B.]

To elucidate the role of tumor vascularization on the localization of adoptively transferred, interleukin 2-activated natural killer (A-NK) cells, pulmonary B16 melanoma metastases were analyzed with respect to location, morphological appearance, origin and density of microvessels, and infiltration by A-NK cells. The B16 melanoma metastases could be divided into four subtypes according to their location (superficial or deep in the lung parenchyma) and morphological appearance (compact or loose). Localization of adoptively transferred A-NK cells into the four subtypes of B16 pulmonary metastases differed significantly. More than 800 A-NK cells/mm2 were found in metastases of the deep-loose type, compared to approximately 400/mm2 A-NK cells in the superficial-loose metastases, and less than 200 A-NK cells/mm2 in the compact subtype, regardless of its location (deep or superficial). Although the origin (pulmonary or bronchial) of the blood supply to the metastatic subtypes (as revealed by electron microscopic analyses of lungs perfused with a lanthanum solution) did not account for this difference, the density of microvessels in the metastatic subtypes correlated with the number of A-NK cells that localized into these metastases. The resistance of metastases of the compact type to infiltration of adoptively transferred effector cells might explain, in part, why adoptive immunotherapy seldom results in complete eradication of disseminated cancer.

1 This study was supported by grants from the Swedish Cancer Society (Grant 1000), Nordic Cancer Union, the Assar Gabrielsson Research Foundation, syskonen Nilssons Research Foundation, the Danish Cancer Society (Grant 90-086), and Kanebo, Ltd., Osaka 534, Japan.

2 To whom requests for reprints should be addressed, at Pittsburgh Cancer Institute, Biomedical Science Tower, W953, 200 Lothrop Street, Pittsburgh, PA 15213.

Received 4/ 3/95. Accepted 8/14/95.




This article has been cited by other articles:


Home page
J. Immunol.Home page
M. H. Kim, R. P. Kitson, P. Albertsson, U. Nannmark, P. H. Basse, P. J. K. Kuppen, M. E. Hokland, and R. H. Goldfarb
Secreted and Membrane-Associated Matrix Metalloproteinases of IL-2-Activated NK Cells and Their Inhibitors
J. Immunol., June 1, 2000; 164(11): 5883 - 5889.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. P. Kitson, P. M. Appasamy, U. Nannmark, P. Albertsson, M. K. Gabauer, and R. H. Goldfarb
Matrix Metalloproteinases Produced by Rat IL-2-Activated NK Cells
J. Immunol., May 1, 1998; 160(9): 4248 - 4253.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1995 by the American Association for Cancer Research.